<DOC>
	<DOCNO>NCT00683423</DOCNO>
	<brief_summary>The purpose study determine whether BMS-741672 improves neuropathic pain diabetic patient .</brief_summary>
	<brief_title>BMS-741672 Diabetic Neuropathic Pain</brief_title>
	<detailed_description />
	<mesh_term>Neuralgia</mesh_term>
	<criteria>Type 1 2 diabetic painful , distal , symmetrical , sensorymotor neuropathy attribute diabetes , least 12 month duration Screening HbA1c ≥ 7 % ≤ 10 % BMI ≤ 40 kg/m2 Patients clinically significant , progressive , potentially unstable disease body system include cardiovascular , gastrointestinal , central nervous system ( CNS ) , psychiatric , endocrine ( diabetes ) , tuberculosis renal Women childbearing potential</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2015</verification_date>
</DOC>